Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Gastroenterology
|
October 28, 2017
Exome-Wide Association Study of Pancreatic Cancer Risk
Robert C Grant, Robert E Denroche, Ayelet Borgida, et al.
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer
Howard L Kaufman, Heinz-Josef Lenz, John Marshall, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas
Benjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
Annals of Surgery
|
October 17, 2024
Vascular Resection for Pancreas Cancer - 10-year Experience from a Single High Volume-center
David Henault, Holden Kunde, Cody Zatzman, et al.
Clinical Colorectal Cancer
|
November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience
Joanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Cancer Medicine
|
December 8, 2023
First impressions: A prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation
Yvonne Bach, Elan Panov, Osvaldo Espin-Garcia, et al.
The New England Journal of Medicine
|
October 18, 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, et al.
NPJ Precision Oncology
|
April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer
Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Gastroenterology
|
October 28, 2017
Exome-Wide Association Study of Pancreatic Cancer Risk
Robert C Grant, Robert E Denroche, Ayelet Borgida, et al.
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer
Howard L Kaufman, Heinz-Josef Lenz, John Marshall, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas
Benjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
Annals of Surgery
|
October 17, 2024
Vascular Resection for Pancreas Cancer - 10-year Experience from a Single High Volume-center
David Henault, Holden Kunde, Cody Zatzman, et al.
Clinical Colorectal Cancer
|
November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience
Joanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Cancer Medicine
|
December 8, 2023
First impressions: A prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation
Yvonne Bach, Elan Panov, Osvaldo Espin-Garcia, et al.
The New England Journal of Medicine
|
October 18, 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, et al.
NPJ Precision Oncology
|
April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer
Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Page
of 13